| Naslov: | Inflammatory biomarkers as predictors of prognosis in patients after transcatheter aortic valve implantation |
|---|
| Avtorji: | ID Vitez, Luka (Avtor)
ID Mihailović, Peter Marko (Avtor)
ID Božič Mijovski, Mojca (Avtor)
ID Jug, Borut (Avtor)
ID Bunc, Matjaž (Avtor) |
|---|
| Datoteke: |  PDF - Predstavitvena datoteka, prenos (780,88 KB)
MD5: 6EB29A27A7992D19B7C9D2C0B6DF9354
 URL - Izvorni URL, za dostop obiščite https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2025.1722293
|
|---|
| Jezik: | Angleški jezik |
|---|
| Tipologija: | 1.01 - Izvirni znanstveni članek |
|---|
| Organizacija: |  UKC LJ - Univerzitetni klinični center Ljubljana
|
|---|
| Povzetek: | Background: The expanding role of transcatheter aortic valve implantation (TAVI) highlights the need to identify factors influencing long-term outcomes. Systemic inflammatory response syndrome (SIRS) is a frequent post-procedural event that may adversely affect prognosis. Measurement of inflammatory biomarkers may improve the understanding of underlying mechanisms and refine patient risk stratification.Methods: This single-center, prospective cohort study, enrolled 62 consecutive patients undergoing TAVI, who were followed for up to 5 years. Blood samples were collected before TAVI, at 24 h and 3–6 months post-procedure. Changes in biomarker levels, predictors of SIRS, and inflammatory predictors of long-term outcomes were analyzed.Results: SIRS developed in 45% of patients. Significant temporal changes were observed in hs-CRP, TNF-α, sST2/IL-33, IL-10, and IL-2 levels, irrespective of baseline or procedural characteristics. The development of SIRS was associated with a higher risk of all-cause mortality or unplanned hospitalization at 5 years (HR 3.07, 95% CI 1.57–6.00; p = 0.001). Baseline hs-CRP (HR 1.21, 95% CI 1.09-1.35; p < 0.001) and IFN-γ (HR 1.22; 95% CI 1.09–1.36; p < 0.001) levels were predictive of adverse outcomes. In multivariable Cox analysis, these associations remained, though findings should be interpreted cautiously given the limited sample size.Conclusions: SIRS is a common post-TAVI phenomenon and may be linked to long-term outcomes. Elevated pre-procedural hs-CRP and IFN-γ levels were associated with higher risk for adverse events, suggesting they may serve as exploratory biomarkers for risk stratification in this population. |
|---|
| Ključne besede: | systemic inflammatory response syndrome, SIRS, transcatheter aortic valve implantation, high sensitivity CRP, hs-CRP, interferon gamma, IFN-γ, inflammatory biomarkers |
|---|
| Status publikacije: | Objavljeno |
|---|
| Verzija publikacije: | Objavljena publikacija |
|---|
| Leto izida: | 2026 |
|---|
| Št. strani: | str. 1-11 |
|---|
| Številčenje: | Vol. 12, [article no.] 1722293 |
|---|
| PID: | 20.500.12556/DiRROS-26988  |
|---|
| UDK: | 616.1 |
|---|
| ISSN pri članku: | 2297-055X |
|---|
| DOI: | 10.3389/fcvm.2025.1722293 |
|---|
| COBISS.SI-ID: | 266429443 |
|---|
| Opomba: | Nasl. z nasl. zaslona;
Opis vira z dne 28. 1. 2026;
|
|---|
| Datum objave v DiRROS: | 28.01.2026 |
|---|
| Število ogledov: | 59 |
|---|
| Število prenosov: | 28 |
|---|
| Metapodatki: |    |
|---|
|
:
|
Kopiraj citat |
|---|
| | | | Objavi na: |  |
|---|
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše
podrobnosti ali sproži prenos. |
